These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3986376)

  • 1. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 4. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 5. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of drug resistance to sarcolysine in plasmacytoma line MORC/406].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Jan; 99(1):90-1. PubMed ID: 3967079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased immunosensitivity in nitrogen mastard-resistant Yoshida sarcoma.
    Tsukagoshi S; Hashimoto Y
    Cancer Res; 1973 May; 33(5):1038-42. PubMed ID: 4703117
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosomal analysis on Yoshida tumor cells sensitive and resistant to dibromodulcitol.
    Gáti E
    Neoplasma; 1979; 26(1):79-83. PubMed ID: 431758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
    Hjarnaa PJ; Jonsson E; Latini S; Dhar S; Larsson R; Bramm E; Skov T; Binderup L
    Cancer Res; 1999 Nov; 59(22):5751-7. PubMed ID: 10582695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of resactin "Dessau" on the survival time of animals bearing nonspecific transplantation tumors (author's transl)].
    Heber J; Hänsel H
    Arch Geschwulstforsch; 1974; 44(1):47-54. PubMed ID: 4447440
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.
    Hingorani P; Zhang W; Piperdi S; Pressman L; Lin J; Gorlick R; Kolb EA
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):733-40. PubMed ID: 19224214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. I].
    Venuti A; Fimiani V; Gioffre' MA; Micali B
    Chir Patol Sper; 1982 Aug; 29(4):161-6. PubMed ID: 7172845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of a bovine thymus extract (TP-1) on implantation and development of Yoshida ascitic sarcoma in the rat. II].
    Venuti A; Gioffre' MA; Micali B; Caputo G
    Chir Patol Sper; 1982 Aug; 29(4):167-71. PubMed ID: 7172846
    [No Abstract]   [Full Text] [Related]  

  • 15. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nitrogen mustard sensitive and resistant Yoshida sarcomas. II. Effect of treatment on cell kinetics.
    Ball CR; Connors TA; Cooper EH; Topping NE
    Neoplasma; 1967; 14(3):253-64. PubMed ID: 6063004
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosomal studies with the nitrogen mustard-sensitive and resistant Yoshida tumour.
    Ujházy V
    Neoplasma; 1968; 15(6):657-61. PubMed ID: 5704185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increase in the generation of superoxide radicals and in the inhibitory effect on Yoshida sarcoma of anthracycline antitumor agents by ultrasound].
    Yumita N; Nishigaki R; Umemura K; Umemura S
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):63-8. PubMed ID: 2544650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats.
    Banerji AP; Fernandes AO
    Cell Biol Int; 1994 Nov; 18(11):1025-34. PubMed ID: 7894388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.